AcclaimIP-ad

Match Document Document Title
10501428 Thymoquinone derivatives for treatment of cancer  
The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
10500411 Cancer cell growth inhibition and killing device using blue light LED  
Provided is a cancer cell growth inhibition and killing device using a blue light LED. The present invention comprises: a bed part which has a top plate on which the body is laid to stand by; a...
10500290 Peptide reagents and methods for detection and targeting of dysplasia, early cancer and cancer  
The present invention is directed to EGFR-specific peptide reagents, methods for detecting pre-cancer, early cancer and/or cancer using the peptide reagents, and methods for targeting pre-cancer...
10500289 Method of using methylene blue nanoparticle for detecting cancer by bioimaging  
The present invention discloses a method for diagnosing and detecting cancer by bioimaging using methylene blue nanoparticle as a contrasting agent. The methylene blue nanoparticle of the present...
10500259 Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10500248 Method for treating cancer  
The present disclosure relates to a method of treating prostate cancer comprising administering to a subject in need thereof a therapeutically effective amount of a vasopressin analogue.
10500224 Mutual prodrug comprising short chain fatty acids and zebularine or 1'-cyano-cytarabine for cancer treatment  
The present invention provides mutual prodrugs comprising anti-cancer nucleosides and short chain fatty acids; methods for production of the mutual prodrugs; methods of treatment comprising...
10500188 Use of a polyenylpyrrole derivative in preparation of anti-oral cancer drugs  
The present invention discloses use of a polyenylpyrrole derivative in preparation of an anti-oral cancer drugs. The polyenylpyrrole derivative synthesized by polyvinylpyrrole, auxarconjugatin A...
10500175 Compositions and methods for the treatment of cancer  
The present invention discloses anti-cancer compositions, and associated methods, including an anti-cancer composition comprising: a cellular energy inhibitor having the structure according to...
10495645 Cancer markers and methods of use thereof  
The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor...
10495644 Methods and systems for cancer diagnosis and prognosis  
The disclosure provides for compositions and methods of making and using a foam composition and its utility in clinical applications.
10495642 Inhibitors of proteins specific for the secretome of a chondrocyte for use in the treatment of breast cancer metastasis  
The present invention relates to a method for identifying inhibitors of breast cancer metastasis based on a screening with proteins that are specific for the secretome of a chondrocyte, preferably...
10494677 Predicting cancer outcome  
This document provides methods and materials related to assessing prostate cancer in mammals. For example, this document provides nucleic acids and polypeptides that can be analyzed to determine...
10494676 Process for the diagnosis of cancer by using exosomes  
The present invention relates to an in vitro process for the diagnosis of prostate cancer and other tumor types in exosomes obtained from a body fluid which comprises a) concentrating the exosomes...
10494675 Methods of detecting cancer  
This invention provides a set of biological markers that are useful for detecting cancer. This invention further provides methods of using those biological markers for the diagnosis, prognosis, or...
10494610 Three dimensional matrix for cancer stem cells  
Synthetic inert 3D gel culture systems are described that can be finely tuned to exhibit desired and predetermined physical, chemical, mechanical, and biochemical properties. The culture system...
10494413 Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10494392 Method of treating cancer with a two-component anti-cancer composition  
Gold(I) complexes and gold(I) dithiocarbamate polymers as anticancer therapeutics. The Au(I) ion within the gold(I) complexes is coordinated to two phosphine ligands. The repeating unit formed by...
10494391 Two-component anti-cancer composition  
Gold(I) complexes and gold(I) dithiocarbamate polymers as anticancer therapeutics. The Au(I) ion within the gold(I) complexes is coordinated to two phosphine ligands. The repeating unit formed by...
10493162 Somatostatin receptor-based cancer therapy  
Methods and composition for cell-based therapy as well as somatostatin receptor-based therapy are described. For example, in certain aspects methods for administering an anti-tumor therapy using a...
10493100 Pharmaceutical composition for preventing or treating brain cancer including crystal polymorph of tetraarsenic hexoxide, and method for preparing same  
The present invention relates to a pharmaceutical composition which is for preventing or treating brain cancer and includes at least 99% of a crystal polymorph of tetraarsenic hexoxide a...
10493076 Method for treating cancer  
The present disclosure relates to pharmaceutical compositions comprising inhibitor(s) of human histone methyltransferase EZH2, and methods of cancer therapy using the EZH2 inhibitor(s).
10492723 Predicting immunotherapy response in non-small cell lung cancer patients with quantitative vessel tortuosity  
Embodiments classify a region of tissue demonstrating non-small cell lung cancer using quantified vessel tortuosity (QVT). One example apparatus includes annotation circuitry configured to segment...
10489908 Deep convolutional encoder-decoder for prostate cancer detection and classification  
A method and apparatus for automated prostate tumor detection and classification in multi-parametric magnetic resonance imaging (MRI) is disclosed. A multi-parametric MRI image set of a patient,...
10489904 Assessing risk of breast cancer recurrence  
The subject disclosure presents systems and computer-implemented methods for assessing a risk of cancer recurrence in a patient based on a holistic integration of large amounts of prognostic...
10489550 Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample  
A programmed computer functioning as a classifier operates on mass spectral data obtained from a blood-based patient sample to predict indolence or aggressiveness of prostate cancer. Methods of...
10488416 Targeting breast cancer therapy based on stromal subtypes and CD146 composition  
Methods for targeted breast cancer therapy in a subject based upon evaluating the stromal subtypes and CD146 composition in the adjacent tissue. ER+ breast cancers contain two CAF subtypes defined...
10488402 System and method for automated determination of the relative effectiveness of anti-cancer drug candidates  
A computer system is provided for determining the relative effectiveness of anti-cancer drugs. The interface has selectable options, including an option to manage drug testing parameters, and...
10487362 Methods for diagnosing cancer based on small nucleolar RNA HBII-52  
Provided are compositions and methods for detecting in a sample the presence or absence, and/or the amount, of a small nucleolar RNA (snoRNA) HBII-52, also known as SNORD115. The compositions and...
10487329 Methods and compositions for the treatment of head and neck cancer  
Disclosed are methods of treating a head and/or neck squamous cell carcinoma in an individual. The method may include the step of administering to an individual a composition comprising an...
10487132 Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10487126 Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10487119 Peptides for diagnosis and treatment of cancer  
A method of peptide histochemical diagnosis to detect the peptide binding protein in the cancer tissue is described. This peptide binding specifically to tumor cells is linked to the dextran...
10487116 Immunotherapy against several tumors, such as lung cancer, including NSCLC  
A method of treating a patient who has glioblastoma and/or gastric cancer includes administering to said patient a composition containing a population of activated T cells that selectively...
10487108 Certain steroids and methods for using the same in the treatment of cancer  
Chemical entities that are novel compounds, pharmaceutical compositions and methods of treatment of cancer are described.
10487107 Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds  
The present invention regards nanoparticles comprising a sterol and a component derived from Quillaja saponaria Molina selected from quillaja acid and quillaja saponin, which nanoparticles do not...
10485859 Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10485858 Cancer stem cell targeted cancer vaccines  
Provided herein are cancer stem cell targeted cancer vaccines and methods for treating and vaccinating against cancer. Also contained herein are regimens by which cancer stem cell targeted cancer...
10485804 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Therapeutic targeting of casein kinase 1δ in breast cancer
 
The invention provides a method of inhibiting casein kinase 1δ (CK1δ), comprising contacting the CK1δ with a compound of formula (I), as defined herein; such as compound SR-3029. We demonstrate...
10485775 Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy  
Disclosed herein are methods for culturing CAR-modified immune cells with at least one Retinoic Acid Receptor and/or Retinoid X Receptor active agent.
10485773 Benzenesulfonamide derivatives and method for treating cancer  
Provided are benzenesulfonamide derivatives or pharmaceutically acceptable salts thereof. Also provided is a method for treating cancer by using a pharmaceutical composition including the...
10485772 Compositions for modulating cancer stem cells and uses therefor  
Disclosed are compositions and methods for modulating cancer stem cells. More particularly, the present invention discloses the use of lysine demethylase (LSD) inhibitors and protein kinase C...
10485769 Cholesteryl ester transfer protein (CETP) inhibition in the treatment of cancer  
In one embodiment, the invention provides methods of treatment which use therapeutically effective amounts of Cholesteryl Ester Transfer Protein (CETP) inhibitors to treat a variety of cancers. In...
RE47731 Kinase inhibitors and method of treating cancer with same  
The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof: Compounds represented by this structural formula are kinase...
10482993 Analyzing copy number variation in the detection of cancer  
The invention provides a method for determining copy number variations (CNV) of a sequence of interest in a test sample that comprises a mixture of nucleic acids that are known or are suspected to...
10481159 IL-6 signaling and breast cancer  
The disclosure provides, inter alia, methods of detecting IL-6 signaling activity in T cells in breast cancer patients, such as breast cancer patients in remission.
10480034 Cancer biomarker and diagnostic  
The application discloses new biomarkers and methods useful in the diagnosis, prognosis and/or monitoring of, or as a therapeutic or research target for, solid tumour cancers, such as colorectal...
10480033 MiRNA-based predictive models for diagnosis and prognosis of prostate cancer  
The lack of clear predictors of prostate cancer progression leads to subjective decision-making regarding courses of treatment. The identification of new biomarkers that are predictive of...
10479997 Compositions and methods for diagnosis and treatment of prostate cancer  
The invention provides novel personalized therapies, kits, transmittable forms of information and methods for use in treating subjects having TMPRSS2:ERG positive prostate cancer, which we show is...
10479979 Method for making and using cold atmospheric plasma stimulated media for cancer treatment  
A method for preparing cold atmospheric plasma stimulated cell culture media with a cold atmospheric plasma system having a delivery port out of which an inert gas flows. The inert gas may be...